SOUTH
SAN FRANCISCO, Calif. and VANCOUVER, BC, May 30, 2024
/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ:
EPIX), a clinical-stage pharmaceutical company focused on
developing novel therapies for the treatment of prostate cancer,
today announced that the Company will be presenting at the
Jefferies Global Healthcare Conference on Thursday, June 6,
2024 at 12:30 p.m. ET in New
York.
David. R. Parkinson, President, and Chief Executive Officer
and David S. Wood, Chief Financial Officer, will host and
participate in one-on-one meetings.
A live webcast of the presentation can be accessed in the
Investors/Events & Presentations section of ESSA's website
at www.essapharma.com. Following the event, the webcast will
be archived on the ESSA website for 90 days.
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on
developing novel and proprietary therapies for the treatment of
patients with prostate cancer. For more information, please
visit www.essapharma.com, and follow us
on Twitter and LinkedIn.
Contacts
ESSA Pharma, Inc.
Peter Virsik, Chief Operating
Officer
778.331.0962
pvirsik@essapharma.com
Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners.com
View original
content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-jefferies-global-healthcare-conference-302158625.html
SOURCE ESSA Pharma Inc